Key insights
- P&G beat Q3 earnings and revenue estimates, driven by broad-based growth. While maintaining full-year EPS guidance, the company expects results towards the lower end due to increased investments and headwinds. The stock rose 1.6%. This positive performance in a defensive sector suggests continued consumer spending, providing a slightly bullish signal for the broader market.
Investing.com -- Procter & Gamble Co. (NYSE: PG) reported third-quarter results that exceeded analyst expectations, with earnings per share and revenue both topping estimates as the consumer products giant delivered broad-based growth across its portfolio.
The company posted adjusted EPS of $1.59 for the quarter, beating the analyst consensus of $1.56 by $0.03. Revenue reached $21.2 billion, surpassing the $20.57 billion estimate and representing a 7% increase from the prior year. Organic sales, which exclude foreign exchange and acquisitions, grew 3% driven by a 2% increase in volume and 1% from higher pricing.
Shares rose 1.6% following the results.
"We delivered a solid acceleration in top-line results in our fiscal third quarter, with broad-based growth across product categories and regions," said Shailesh Jejurikar, President and Chief Executive Officer. "We’re increasing investments to accelerate momentum with consumers despite the challenging geopolitical and economic environment, while still maintaining our guidance ranges for the fiscal year."
P&G maintained its full-year fiscal 2026 core EPS guidance range of $6.83 to $7.09, though the midpoint of $6.96 sits slightly above the analyst consensus of $6.94. However, the company indicated it expects results toward the lower end of this range due to increased investments in innovation and demand creation, as well as headwinds from tariffs and commodities.
All five business segments delivered organic sales growth. Beauty led with 7% organic sales growth, driven by innovation-based pricing and volume gains. Fabric & Home Care and Baby, Feminine & Family Care each grew 3%, while Health Care increased 2% and Grooming rose 1%.
P&G maintained its outlook for organic sales growth of flat to up 4% for the fiscal year.